Maven Shifts to Direct to Consumer Billing

This marks Maven shifting from an employer software vendor into a real consumer healthcare seller. Instead of only getting paid by HR teams for access and reimbursement administration, Maven can now charge individuals directly for ongoing GLP-1 care, hormone care, and virtual visits across its provider network. That gives Maven its own demand engine, its own payment relationship, and a way to monetize members even when no employer is involved.1 2 3

• Maven’s core business was built around employers paying platform fees and per member pricing for fertility, maternity, and family benefits, with estimates of $700 to $950 per enrolled member plus a $20,000 to $40,000 platform fee. The consumer launch adds a second revenue model that does not depend on benefits budgets or annual HR sales cycles.1 2
• The closest analogs are D2C telehealth companies like Ro and consumer subscriptions like Function Health. Ro shows how direct billing works in practice, with monthly care subscriptions layered on top of drug fulfillment for GLP-1 care, while Function shows how recurring consumer health spend can be packaged into membership. Maven is applying that playbook to women’s and family health.3 4
• This also separates Maven from fertility benefits peers like Progyny and Kindbody. Progyny is primarily an employer benefits manager, and Kindbody mixes employer contracts with clinic revenue. Maven now sits in between, still asset light and employer led, but with a direct consumer front door that can capture cash pay demand for menopause, hormones, weight loss, and general virtual care.1 2 5

The next step is for Maven to connect both sides of the business so employer members can start inside a covered benefit and later keep paying out of pocket for adjacent care. If that works, Maven becomes less like a point solution sold to HR and more like a lifelong women’s health platform with both B2B and D2C revenue streams.1 2 3 5